Healthpeak Properties, Inc. $DOC Shares Sold by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. reduced its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 16.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,398 shares of the real estate investment trust’s stock after selling 8,000 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Healthpeak Properties were worth $725,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Healthpeak Properties by 584.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock valued at $186,405,000 after buying an additional 7,872,150 shares during the last quarter. Nuveen LLC purchased a new stake in Healthpeak Properties during the first quarter worth about $124,113,000. Invesco Ltd. boosted its stake in shares of Healthpeak Properties by 20.7% during the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock worth $467,311,000 after acquiring an additional 3,967,830 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in Healthpeak Properties by 57.8% in the first quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust’s stock valued at $136,785,000 after purchasing an additional 2,477,307 shares during the last quarter. Finally, Amundi boosted its stake in shares of Healthpeak Properties by 89.4% during the first quarter. Amundi now owns 5,047,699 shares of the real estate investment trust’s stock valued at $98,228,000 after acquiring an additional 2,382,657 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on DOC shares. Morgan Stanley dropped their target price on Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a research note on Friday, August 22nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Healthpeak Properties in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $18.00 target price (down from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Wells Fargo & Company cut their price target on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 27th. Finally, Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research note on Monday, September 15th. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $21.33.

Insider Buying and Selling at Healthpeak Properties

In related news, CEO Scott M. Brinker acquired 1,490 shares of Healthpeak Properties stock in a transaction that occurred on Monday, August 4th. The stock was acquired at an average price of $16.83 per share, with a total value of $25,076.70. Following the completion of the acquisition, the chief executive officer directly owned 211,906 shares of the company’s stock, valued at $3,566,377.98. This trade represents a 0.71% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have bought 8,783 shares of company stock worth $150,129 in the last quarter. 0.23% of the stock is owned by insiders.

Healthpeak Properties Stock Performance

DOC opened at $18.71 on Tuesday. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. The business’s 50 day moving average is $18.20 and its 200-day moving average is $17.89. The stock has a market cap of $13.00 billion, a PE ratio of 77.94, a price-to-earnings-growth ratio of 3.16 and a beta of 1.09. Healthpeak Properties, Inc. has a twelve month low of $16.63 and a twelve month high of $23.26.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. The firm had revenue of $694.35 million for the quarter, compared to analysts’ expectations of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm’s revenue was down .2% compared to the same quarter last year. During the same period last year, the firm earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be paid a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 6.5%. The ex-dividend date is Friday, December 19th. Healthpeak Properties’s payout ratio is currently 508.33%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.